Bota Bio logo

Industrial biotech Bota Bio secures $100M in Series B financing

Pfizer-BioNTech

Pfizer highlights COVID-19 and flu vaccine strategy in Q2 earnings call

Satsuma

Satsuma launches Phase 3 trial for acute migraine drug 

Takeda

FDA grants breakthrough therapy designation to Takeda narcolepsy drug candidate

Pfizer-BioNTech

Preprint shows strong but fading efficacy of Pfizer vaccine at six months

Biogen/Eisai

Aducanumab continues to face scrutiny as Biogen aims to woo neurologists and Alzheimer’s patients

Novartis

FDA grants orphan drug designation to investigational Novartis drug NIS793

Merck

FDA approves Merck’s Keytruda to treat certain types of breast cancer

FDA logo

FDA seeks comments on psychotropic substances, including kratom